Men who want to do everything they can to reduce their risk of prostate cancer, should strongly consider adopting a Mediterranean diet way of eating.
Read MoreA bone scan is an imaging test that may be used to detect cancerous cells, evaluate fractures in bones or to monitor bone conditions such as infections and arthritis.
Read MoreHIFU may not be for every man who is diagnosed with prostate cancer. Like any cancer diagnosis, there needs to be an individualized care plan to best meet the needs of the patient.
Read MoreHere are 20 ideas on how to get all the essential nutrients, vitamins and minerals needed for a balanced diet increasing the odds of beating back prostate cancer.
Read MoreThe spread of prostate cancer may be suspected if there are certain symptoms. If a man is experiencing lower back pain this could indicate his prostate cancer may have metastasized to the lower spine.
Read MoreWhen a man goes to a doctor for a prostate exam and is told he has prostate nodules, is this a cause for concern and does it indicate prostate cancer?
Read MoreDeveloped by Dr. Donald Gleason in 1966, the Gleason score is a grading system for prostate cancer still bearing his name today which is used to grade the aggressiveness of prostate cancer tissue.
Read MoreProstate specific antigen (PSA) is a protein produced by cells of the prostate gland in men. A man may have a PSA blood test measuring the level of PSA in a man’s blood with the results reported as nanograms of PSA per milliliter (ng/ml) of blood.
Read MoreProstate cancer found in men growing very slowly, may never need to be treated. Instead, an approach a doctor may use in this circumstance is called active surveillance or watchful waiting.
A biopsy of the prostate is done when a blood test shows a high level of prostate specific antigen (PSA).
Read MoreProstate cancer is the most common cancer in American men other than skin cancer. It affects about one in seven men and estimates for prostate cancer in the United States for 2018
Read MoreThis news is from a prospective validation study showing that it has the potential to reduce the number of unnecessary prostate biopsies substantially.
